Innoveren Scientific Inc. (IVRN)

Market Cap	188.00
Revenue (ttm)	1.61M
Net Income (ttm)	-7.28M
Shares Out	n/a
EPS (ttm)	-30.00
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	223,460
Open	n/a
Previous Close	0.0200
Day's Range	n/a
52-Week Range	0.0003 - 3.7300
Beta	0.64
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About IVRN

Innoveren Scientific Inc., a medical bioscience company that develops technology in regenerative medicine for limb salvage. It is also developing immunotherapies for ovarian cancer, pancreatic cancer, and mesothelioma. The company was formerly known as H-CYTE, Inc. and changed its name to Innoveren Scientific Inc. in July 2023. The company is headquartered in Tampa, Florida.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2013
• Employees: 2
• Stock Exchange: OTCMKTS
• Ticker Symbol: IVRN

Financial Performance

In 2021, IVRN's revenue was $1.61 million, a decrease of -25.07% compared to the previous year's $2.15 million. Losses were -$4.80 million, -29.23% less than in 2020.